
TSE:FFH
This summary was created by AI, based on 22 opinions in the last 12 months.
Fairfax Financial (FFH-T) presents a mix of opinions among analysts, characterized by a stable yet turbulent market presence. While it boasts a solid reputation as a well-managed company with strong long-term growth potential, particularly in its insurance sector, many experts imply that the current market conditions are not optimal for buying. Reviews suggest a sideways trend in stock performance without any significant catalysts on the horizon, with some indicating that the best earnings cycle may be behind. Moreover, the stock tends to trade at a discount compared to peers, hinting at potential undervaluation, but several analysts believe that it may not be a screaming buy at this moment. The long-term outlook remains positive, though considerable patience is required to fully appreciate the investment's value.
All of his Top Picks today have no momentum or key catalysts. Just excellent, well-run businesses that will add long-term value. Doesn't know how they'll look 1 year from now, but will certainly look good 3-5 years hence.
Today's a pretty good entry point. Compounded 19% a year since the IPO. Its insurance business has really improved (you have to be good at underwriting and at investing the money). Not a trade, you buy it for the long term. Everybody who works there owns shares, so what better incentive can you have? Yield is 0.89%.
Q4 results last week were very good -- earnings stronger than expected, underwriting was fantastic, combined ratio was very strong. Big hit of catastrophe losses. You need to look at the long-term improvements the company's made, which he expects to continue.
Unlike most P&C companies, makes acquisitions the way BRK does. Big footprint in India, and looking to make a banking acquisition there (good chance of success, and this would add another trophy asset).
They reported last week and beat the street by a mile. Prem Watsa is viewed at the Warren Buffet of Canada and FFH trades at a discount because of him. FFH is a lot more investment-focused than peers. Intact trades at 2.4x price-to-book vs. FFH 1.3x, a very big discount.
(Analysts’ price target is $1974.15)Watching closely. Results for 2025 are definitely making her more interested. At 1.8x book not really deep value, but not unreasonable for such a quality compounder. Potential upside of 26%, but has not hit analysts' targets once in last 5 years. Expects decent return, but unlikely to be the best in the sector.
Reported best year in history. Firing on all cylinders. Taking more in than paying out, and can invest the rest. Lumpy earnings, harder to predict.
In the space, she owns SLF instead.
Has done so well because it's been on the right side of the interest rate trade, plus underwriting operations have improved. Not a screaming buy today -- easy money has been made over the last 2 years. You're now paying a fair price for a fair asset, still attractive.
He'd much rather buy IFC on the dips.
Dead money for several years, and now on fire. Increased book value per share and growth profile. Improved underwriting ability. Benefits from lower catastrophic losses, which happened last quarter. Robust operating income. Buybacks, dividend growth.
At 12x PE for 2027, not a buy right now. Doesn't see too much growth for 2026-27, other than rising book value per share. There are more "divendy" stocks out there for an RRSP. But a good-quality holding.
Because of the company's style, we can't do much about the earnings volatility. Value investments go in and out of favour, and monetization of assets can occur at anytime and skew results materially. 2018 to 2021 we think was an abberation. FFH barely made any money in 2018 and lost money in 2020. The past four years have been fabulous, yet the stock trades at 9X earnings. If we look at consensus numbers (with the same degree of uncertainty), analysts do expect very strong EPS for the next five years ($95 per share to $184). We might guess (not a prediction) for 15% earnings growth. We would be comfortable buying as long as an investors understands the company and has patience. The dividend is not great but there is at least 0.90% while one waits. But we think its long term record override the weak five year period.
Unlock Premium - Try 5i Free
Great Canadian company. Values scores 8/10, fundamentals 9/10. P&C insurer plus invests in a wide range of businesses, and results can be mixed because of this investment style. Known for taking big bets, which can lead to big wins or big misses. Making strategic portfolio moves. Sees upside from here of potentially 20%. Outperformed most of its insurance peers. Reasonable PE of 8.4x, and that's an opportunity. Analysts see it as Undervalued by as much as 65%. On her watchlist.
Likes the insurance space and sees a lot of opportunity there. This is a solid pick for investors who want exposure to the sector in more of a contrarian way. A mini-Berkshire Hathaway.
Fairfax Financial is a Canadian stock, trading under the symbol FFH.TO (previously FFH-T on Stockchase) on the Toronto Stock Exchange (FFH-CT). It is usually referred to as TSX:FFH or FFH.TO
In the last year, 24 stock analysts issued a Buy, Sell, or Hold rating on FFH.TO (previously FFH-T on Stockchase). 15 analysts recommended to BUY and 4 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Fairfax Financial.
Fairfax Financial was recommended as a Top Pick by Bruce Murray on 2025-11-11. Read the latest stock experts ratings for Fairfax Financial.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Fairfax Financial.
Fairfax Financial is followed by 280 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-25, Fairfax Financial (FFH.TO) stock closed at a price of $2,340.67.
Trend is sideways, and 200-day MA has started to roll over. Not a great technical structure. Market might think best part of the earnings cycle is behind it. Neither cheap nor expensive. Need to see some catalysts before it becomes attractive.